Mastectomy Clinical Trial
Official title:
Reduction of Post Mastectomy Pain With the Jacki® Recovery Jacket: Randomized Trial
NCT number | NCT02976103 |
Other study ID # | 16-403 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | March 7, 2017 |
Est. completion date | January 11, 2018 |
Verified date | February 2020 |
Source | Dana-Farber Cancer Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This research study is studying a garment called the Jacki® recovery jacket that can be worn
after surgery as a possible way to manage pain from surgical drains.
The study intervention involved in this study is:
-"Jacki" recovery jacket
Status | Completed |
Enrollment | 139 |
Est. completion date | January 11, 2018 |
Est. primary completion date | January 11, 2018 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients who are = 18 years old. - Patients who speak and understand English. - Patients who have had mastectomy with reconstructive surgery in one or both breasts. Exclusion Criteria: - Co-morbid delirium - Dementia - Mental illness, or neurocognitive deficit prohibiting informed consent and/or ability to complete study procedures. |
Country | Name | City | State |
---|---|---|---|
United States | Brigham and Women's Faulkner Hospital | Boston | Massachusetts |
United States | Dana Farber Cancer Institute | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Dana-Farber Cancer Institute | Daisy Foundation |
United States,
Berry DL, Blonquist TM, Halpenny B, Hong F, Morrison-Ma SC, McCullough MC, Carelli K, Dominici LS, King TA. The Jacki Jacket after mastectomy with reconstruction: a randomized pilot study. Breast Cancer Res Treat. 2020 Jan;179(2):377-385. doi: 10.1007/s10 — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pain Intensity (on the 0-10 Pain Intensity Numeric Scale) | Pain Intensity Numeric Scale (0-10)(higher scores = worse outcome) | 1-2 weeks | |
Secondary | Symptom Distress Scale - Pain Frequency | 1 item (score range 1-5); higher score = worse outcome | 1-2 weeks | |
Secondary | Symptom Distress Scale - Pain Intensity | 1 item (score range 1-5); higher score = worse outcome | 1-2 weeks | |
Secondary | PROMIS Pain Intensity Scale (Short Form 3a) | 3 items (T score 0-100); higher score = worse outcome | 1-2 weeks | |
Secondary | PROMIS Pain Interference Scale - Short Form 8a | 8 items (T score 0-100); higher score = worse outcome | 1-2 weeks | |
Secondary | EORTC QLQ-C30: Global QOL Scale | 2 items; score range 0-100 (higher score = better outcome) | 1-2 weeks | |
Secondary | EORTC QLQ-C30: Physical Functioning Scale | 5 items; score range 0-100 (higher score = better outcome) | 1-2 weeks | |
Secondary | EORTC QLQ-C30: Role Functioning Scale | 2 items; score range 0-100 (higher score = better outcome) | 1-2 weeks | |
Secondary | EORTC QLQ-C30: Emotional Functioning Scale | 4 items; score range 0-100 (higher score = better outcome) | 1-2 weeks | |
Secondary | EORTC QLQ-C30: Cognitive Functioning Scale | 2 items; score range 0-100 (higher score = better outcome) | 1-2 weeks | |
Secondary | EORTC QLQ-C30: Social Functioning Scale | 2 items; score range 0-100 (higher score = better outcome) | 1-2 weeks | |
Secondary | EORTC QLQ-BR23: Body Image Subscale | 4 items (score 0-100); higher score = worse outcome | 1-2 weeks | |
Secondary | EORTC QLQ-BR23: Sexual Functioning Subscale | 2 items (range 0-100); higher score = better outcome | 1-2 weeks | |
Secondary | EORTC QLQ-BR23: Sexual Enjoyment Subscale | 1 item (range 0-100); higher score = better outcome | 1-2 weeks | |
Secondary | EORTC QLQ-BR23: Future Perspective Subscale | 1 item (range 0-100); higher score = worse outcome | 1-2 weeks | |
Secondary | EORTC QLQ-BR23: Systemic Therapy Side Effects Subscale | 7 items (range 0-100); higher score = worse outcome | 1-2 weeks | |
Secondary | EORTC QLQ-BR23: Breast Symptoms Subscale | 4 items (range 0-100); higher score = worse outcome | 1-2 weeks | |
Secondary | EORTC QLQ-BR23: Arm Symptoms Subscale | 3 items (range 0-100); higher score = worse outcome | 1-2 weeks | |
Secondary | EORTC QLQ-BR23: Upset by Hair Loss Subscale | 1 item (range 0-100); higher score = worse outcome | 1-2 weeks | |
Secondary | Pain Patterns At Home: Average Daily Pain Intensity (Daily Diary) | Average 0-10 Pain Intensity Numeric Scale Rating, for 7 days post-discharge, if at least 5 days reported (T2 diary) | 1 week | |
Secondary | Pain Management At Home: Use of Pain Medication (Daily Diary) | Participant self-report of average daily morphine eqivalent dose taken in first 7 days post-discharge (if at least 5 days reported) | 1-2 weeks | |
Secondary | Pain Management At Home: Use of Mastectomy Bra (Daily Diary) | Self-reported proportion of days in the first 7 days post discharge that participant wore a mastectomy bra (if at least 5 days reported) | 1-2 weeks | |
Secondary | Pain Management At Home: Use of Mastectomy Camisole (Daily Diary) | Self-reported proportion of days in the first 7 days post discharge that participant wore a mastectomy camisole (if at least 5 days reported) | 1-2 weeks | |
Secondary | Patient-Reported Usage of Jacki Recovery Jacket (Daily Diary) | Self-reported proportion of days in the first 7 days post-discharge that participant wore the Jacki recovery jacket at all; no score is better or worse | 1-2 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03618433 -
KİNECT® - Video Games Based Physiotherapy Programme in Patients With Breast Cancer Surgery
|
N/A | |
Terminated |
NCT05395936 -
Mastectomy Flap Temperature Study
|
N/A | |
Recruiting |
NCT03757793 -
Near-infrared Spectroscopy for Monitoring Tissue Oxygenation in Breast Reconstruction
|
||
Completed |
NCT01781299 -
Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTU
|
Phase 4 | |
Completed |
NCT01176786 -
Reusable Versus Disposable Draping System in Breast Reconstruction Surgery
|
N/A | |
Terminated |
NCT00616824 -
The Use of an Acellular Dermal Matrix in a Two-Staged Breast Reconstruction
|
Phase 4 | |
Recruiting |
NCT06033456 -
Combining Stellate Ganglion and T2 and T3 Radiofrequency Ablation on Post-mastectomy Complex Regional Pain Syndrome
|
N/A | |
Recruiting |
NCT05975359 -
Assessment of the Interi Manifold in Implant-Based Breast Reconstruction
|
N/A | |
Withdrawn |
NCT03135392 -
Sensation After Nipple Sparing Mastectomy and Breast Reconstruction With or Without Neurotized Free Tissue Transfer
|
N/A | |
Recruiting |
NCT01217593 -
Ultrasound vs. Predetermined Distance Techniques for Paravertebral Nerve Block in Patients Having Breast Surgery
|
N/A | |
Completed |
NCT01231204 -
Prevention of Post-Mastectomy Breast Pain Using Ambulatory Continuous Paravertebral Blocks
|
Phase 4 | |
Recruiting |
NCT05069805 -
Comparison of Erector Spinae Plane Block and Pectoral Nerve Block for Acute and Chronic Pain in Mastectomies
|
N/A | |
Completed |
NCT01687348 -
Lidocaine Pharmacokinetics During Tumescent Infiltrative Anaesthesia for Mastectomy
|
Phase 3 | |
Completed |
NCT00555503 -
Registry of Mastectomy for Breast Cancer Risk Reduction
|
N/A | |
Recruiting |
NCT03598712 -
Local Compression Seroma DIminution Objective (CLODIS)
|
Phase 3 | |
Not yet recruiting |
NCT04457167 -
Mastectomy With Retention of the Nipple-areola Complex, Robot-assisted or Not, and / or Immediate or Seconday Reconstruction by Latissimus Dorsi Flap, Robot-assisted or Not.
|
N/A | |
Recruiting |
NCT05494502 -
Impact of Erector Spinae Plane Block on Chronic Postsurgical Pain in Breast Cancer Patients
|
N/A | |
Recruiting |
NCT02894021 -
PREvention of Post-mastectomy LYMphoceles by PAdding
|
N/A | |
Recruiting |
NCT04891510 -
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
|
N/A | |
Enrolling by invitation |
NCT05658367 -
Effect of Aromatherapy Massage on Pain and Anxiety After Mastectomy
|
N/A |